Sampedro JA. Sarcoidosis. Medellín, 1989. 45 p. Tesis (Especialista en Medicina Interna). Universidad de Antioquia. Facultad de Medicina, Departamento de Medicina Interna.

Crystal RG. Sarcoidosis In: Wilson JD, Braunwald E, Isselbacher KJ et al, eds. Harrison's Principles of Internal Medicine, Twelfth Edition, McGraw-Hill, Inc, 1991; 1463-1469.

Savin JA. Sarcoidosis En: Champion RH, Burton JL, Ebling FJG eds. Textbook of Dermatology. Fifth Edition. Oxford: Blackwel Scientific Publications, 1992; 2383-2406.

Gundy KV, Sharma OP. Pathogenesis of Sarcoidosis. Wist J Med 1987; 168-174.

Lever WF. Schaumburg G. Noninfectious Granulomas In: Histopatology of the skin. Seventh Edition. Philadelphia: J.B. Lippincott Company, 1990; 252-256.

Sharma OP. Sarcoidosis of the skin In: Fitzpatrick TB. Eisen AZ. Wolf K et al, eds Dermatology in General Medicine, Fourth Edition. McGraw-Hill, Inc. 1993; 2221-2228.

Petrek M, Kolek V. Determination of T-lymphocyte subsets in bronchoalveolar lavage of patients with pulmonary sarcoidosis. Acta-Univ-Palacki-Olomuc-Fac-Med. 1991; 130: 169-177.

Popp W, Herkner K, Boch A et al. Influences of the cellular and humoral unmune system in bronchoalveolar lavage on lung function in pulmonary sarcoidosis. Respiration 1992; 59(2): 89-93.

https://doi.org/10.1159/000196033

Spiteri MA, Clarke SW, Poulter LW. Alveolar macrophages that suppress T cell responses may be crucial to the pathogenetic outcome of pulmonary sarcoidosis Eur Respir J. 1992 Apr; 5(4): 394-403.

Bjermer L, Eklund A, Blaschke E. Bronchoalveolar lavage fibronectin in patients with sarcoidosis: Correlation to hyaluroanan and disease activity. Eur Respir J 1991 Sep; 4(8): 965-971.

Melis M, Gjomarkaj M, Pace E et al. Increased expression of leukocyte function associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) by alveolar macrophages of patients with pulmonary sarcoidosis. Chest. 1991 Oct; 100(4): 910-916.

https://doi.org/10.1378/chest.100.4.910

Popp W, Wachtler FJ. Correlation of morphological patterns of nucleoli in alveolar macrophages with HLA-DR antigen expression in sarcoidosis. Thorax. 1991 Dec; 46(12): 878-880.

https://doi.org/10.1136/thx.46.12.878

Pettersen HB. Johnson E, Garred P et al. Quantification of non-activated (native) complement component C9 synthesized by alveolar macrophages from patients with sarcoidosis. Scand J Inmunol 1990 May; 31(5): 657-663.

https://doi.org/10.1111/j.1365-3083.1990.tb02816.x

Pettersen HB, Johnson E, Mollnes TE et al. Synthesis of complement by alveolar macrophages from patients with sarcoidosis. Scand J Inmunol 1990 Jan; 31(1): 15-23

https://doi.org/10.1111/j.1365-3083.1990.tb02738.x

Shumacher HR, Jr Sarcoidosis. En: McCarty DJ, Koopman W] eds. Arthritis and Allied Conditions A Texbook of Rheumatology. Twelfth edition Philadelphia London Lea & Febeger, 1993; 1449-1455.

Muthiah MM, Macfarlane JT. Current concepts in the management of sarcoidosis. Drugs. 1990; 40(2): 231-237.

https://doi.org/10.2165/00003495-199040020-00005

Van-Maarseveen TC, Mullink H, Stam J et al. Macrophage-T suppresor cell interference in the lungs of steroid-treated sarcoidosis patients Am Rev Respir Dis. 1991 Apr; 143(4 Pt 1): 839-843.

https://doi.org/10.1164/ajrccm/143.4_Pt_1.839

Baughman RP. Lower EE. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am Rev Respir Dis. 1990 Dec; 142 (6 Pt 1): 1268-1271

https://doi.org/10.1164/ajrccm/142.6_Pt_1.1268

Israel HL, McComb Bl. Chlorambucil treatment of sarcoidosis. Sarcoidosis. 1991 Mar; 8(10): 35-41.

York EL, Kovithavongs T. Man SF et al. Cyclosporine and chronic sarcoidosis. Chest. 1990 Oct; 98(4): 1026-1029.

https://doi.org/10.1378/chest.98.4.1026

Zic JA, Horowitz DH, Arzubiaga C et al Treatment of cutaneous sarcoidosis with chloroquine. Review of the literature. Arch Dermatol 1991 Jul: 127(7); 1034-1040

https://doi.org/10.1001/archderm.127.7.1034